大麻素及其衍生物在的分子标 - - 一篇专注于CBD的综述
Sebastian Marciniak1, Weronika Wasyluk2, Andrzej Wojtak3
1Department of Pharmacology, Faculty of Health Sciences, Medical University of Lublin, Lublin, Poland.
Acta biochimica Polonica
|October 16, 2025
概括
大麻素对治疗,包括耐药形式的治疗有前途. 研究探讨了它们的分子效应和与其他治疗方法的协同作用,以改善患者护理和减少不良反应.
科学领域:
- 神经科学和药理学 神经科学和药理学
- 分子生物学分子生物学
- 医学化学 医学化学
背景情况:
- 大麻素及其衍生物正在越来越多地研究其在中的治疗潜力.
- 现有的治疗方法,特别是耐药形式,存在局限性,因此需要新的治疗策略.
- 当与常规化疗药物相结合时,大麻素可能会提供协同效应,从而提高治疗效率.
研究的目的:
- 审查各种大麻素 (例如,CBD,Δ9-THC,CBDV) 在治疗中的分子机制.
- 探索大麻素受体,酶,离子通道和载体在活动中的作用.
- 增强医生对类药物治疗的理解,包括潜在的益处和不良影响.
主要方法:
- 关于大约150篇同行评审科学文章的综合文献评论.
- 分析特定大麻素的分子效应及其在相关的生物系统中的相互作用.
- 专注于诸如 Δ9-THC, CBDV, Δ9-THCA, Δ9-THCV, H2CBD 和 CBD 这样的化合物.
主要成果:
- 大麻素显示出治疗的潜力,包括耐药病例.
- 证据表明,大麻素和化疗药物之间存在有益的协同作用,改善治疗结果.
- 了解大麻素的分子标对于优化其治疗应用至关重要.
结论:
- 大麻素是治疗的替代疗法和辅助疗法的有希望的途径.
- 对大麻素药理学的进一步研究可以导致改善治疗策略和患者护理.
- 关于大麻素使用的知情临床决策需要了解它们的分子作用和潜在的副作用.
相关概念视频
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...